Keep yourself up to date
SEATTLE, WA, December 20, 2016 — Cyrus Biotechnology, Inc., a new biotechnology software company offering the most advanced protein modeling and design capabilities to the Biopharmaceutical, Synthetic Biology, Chemical, and Consumer Products industries is presenting at the Biotech Showcase January 9 at 5:15PM in San Francisco. Dr. Lucas Nivon, CEO of Cyrus, will present an […]
Cyrus CSO Yifan Song, along with lead author Ray Wang from the University of Washington and PI Frank DiMaio have published an important next step in the progress towards making Cryo-Electron Microscopy (cryo-EM) a vital new tool in drug discovery. In their manuscript published in the journal eLife, “Automated structure refinement of macromolecular assemblies from […]
Cyrus’s CTO Javier Castellanos was featured in a story on Chile Global, the website of a Chilean entrepeneur’s group focused on connecting Chileans who are making a big impact abroad with their home country. The article describes Javier’s path from being a Biochemistry undergrad in Chile to co-founding Cyrus Biotechnology. It focuses on the key role his […]
Scientists in the UW IPD and David Baker’s lab there have been designing mini-proteins up to 120 residues over the last few years, in a slew of exciting research papers in protein design. Now for the first time they’ve designed short cyclic peptides in the range 18-47 residues — constrained for example by N to […]
Xconomy hosted Cyrus, Prof. David Baker of the University of Washington’s IPD, and founders of two other spin-outs from the IPD, Virvio and PVP Biologics, at their EXOME mini-symposium in Seattle. Geekwire gives a great summary of the current state of computational protein design.